Exchange: NASDAQ·Updated 04:00 PM EST

SVA News

News
all
press releases
SINOVAC Reports Unaudited First Half of 2026 Financial Results
Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced it filed its unaudited financial results for the six months ended June 30, 2026 with the U.S. Securities and Exchange Commission. An electronic copy of the...
Business Wire
SINOVAC Reports Unaudited First Half of 2026 Financial Results
Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced it filed its unaudited financial results for the six months ended June 30, 2026 with the U.S. Securities and Exchange Commission. An electronic copy of the...
Business Wire
More News
Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Companys previously declared special cash...
Business Wire
Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (the "Notification Letter"), from Hearing Advisor of The Nasdaq Stock Market LLC., indicating that...
Business Wire
Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 (the Annual Report) with the U.S. Securities and Exchange Commission. An...
Business Wire
Sinovac Biotech Ltd. (Nasdaq: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the Notification Letter), from Nasdaq Listing Qualifications (Nasdaq) stating that as of May 8, 2026...
Business Wire
Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Companys previously declared special cash...
Business Wire
Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the six months ended June...
Business Wire
Sinovac Biotech Ltd. (Nasdaq: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the fiscal...
Business Wire
Sinovac Biotech Ltd. (Nasdaq: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that the Nasdaq Hearings Panel (the Panel) has granted the...
Business Wire
(RTTNews) - Sinovac Biotech Ltd. (SVA) announced an update on the Antigua High Court's interlocutory order regarding the Company's board composition and corporate actions pending trial. The Company...
Nasdaq News: Markets

Advertisement|Remove ads.